Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antifolate
    (3)
  • ADC Antibody
    (1)
TargetMol | Tags By Application
  • ELISA
    (3)
  • Functional assay
    (3)
  • FCM
    (2)
  • FACS
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (2)
Filter
Search Result
Results for "

mirvetuximab

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    3
    TargetMol | Inhibitory_Antibodies
  • ADC/ADC Related
    1
    TargetMol | All_Pathways
  • Mirvetuximab
    M9346A
    T767661453084-36-0
    Mirvetuximab (M9346A) is a novel folate receptor α (FRα) monoclonal antibody targeting anti-FOLR1 (folate receptor 1). Mirvetuximab soravtansine is often conjugated with platinum compounds or other compounds to form antibody-drug conjugates for the treatment of ovarian cancer and other FRα-positive cancers.
    • $322
    In Stock
    Size
    QTY
  • Mirvetuximab soravtansine
    TAK-853, IMGN-853, IMGN853
    T778251453084-37-1
    Mirvetuximab soravtansine (IMGN853) is an antibody-drug coupling (ADC) targeting folate receptor alpha (FRα), which inhibits cell growth and enhances the antiproliferative effects of DNA damage, and may be useful in the study of drug-resistant ovarian cancer.
    • $738
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Hot
    TargetMol | Citations Cited
  • Mirvetuximab MMAE
    T9901A-218
    Mirvetuximab-MMAE , an Anti-FOLR1 Reference Antibody, is produced in CHO cells. This antibody features a huIgG1 heavy chain and a hukappa light chain, with a predicted molecular weight (MW) of 145.96 kDa.
    • Inquiry Price
    Inquiry
    Size
    QTY